Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10882778 | 0.78 | VCAM1 (0.69) | VCAM1ALDH1A1CA9HTTLMNA | |
| SCHEMBL31022541 | 0.74 | VCAM1 (0.50) | VCAM1ALDH1A1CA9HTTLMNA | |
| SCHEMBL11676296 | 0.73 | POLB (0.49) | VCAM1ALDH1A1HTTLMNATDP1 | |
| SCHEMBL6261490 | 0.72 | VCAM1 (1.00) | VCAM1ALDH1A1 | |
| SCHEMBL31022439 | 0.72 | VCAM1 (0.69) | VCAM1ALDH1A1HTTLMNAMAPK1 | |
| SCHEMBL1067773 | 0.71 | HTT (0.44) | ALDH1A1HTTLMNAMAPK1TDP1 | |
| SCHEMBL12631363 | 0.71 | VCAM1 (0.43) | VCAM1ALDH1A1CA9HTTLMNA | |
| SCHEMBL10694269 | 0.71 | CA1 (0.53) | VCAM1ALDH1A1CA9LMNAKMT2A | |
| SCHEMBL23092340 | 0.70 | VCAM1 (0.65) | VCAM1ALDH1A1CA9HTTMAPK1 | |
| SCHEMBL3012755 | 0.69 | GPR35 (0.52) | ALDH1A1HTTLMNAMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4656629-A1 | INDOLE DERIVATIVE WITH SUBSTITUENT AND PHARMACEUTICAL USE | MitoImmune Therapeutics Inc. (KR) | 2025-12-03 | — | — | EP | disclosed |
| WO-2024158205-A1 | INDOLE DERIVATIVE WITH SUBSTITUENT AND PHARMACEUTICAL USE | 주식회사 미토이뮨테라퓨틱스 | 2024-08-02 | — | — | WO | disclosed |